KLIFS: a structural kinase-ligand interaction database
By Albert J. Kooistra, Georgi K. Kanev, O. Linden, R. Leurs, I. D. Esch, C. Graaf. 2015
157 citations recorded by the source corpus.
Protein kinases play a crucial role in cell signaling and are important drug targets in several therapeutic areas. The KLIFS database contains detailed structural kinase-ligand interaction information derived from all (>2900) structures of catalytic domains of human and mouse protein kinases deposited in the Protein Data Bank in order to provide insights into the structural determinants of kinase-ligand binding and selectivity. The kinase structures have been processed in a consistent manner by systematically analyzing the structural features and molecular interaction fingerprints (IFPs) of a predefined set of 85 binding site residues with bound ligands. KLIFS has been completely rebuilt and extended (>65% more structures) since its first release as a data set, including: novel automated annotation methods for (i) the assessment of ligand-targeted subpockets and the analysis of (ii) DFG and (iii) αC-helix conformations; improved and automated protocols for (iv) the generation of sequence/structure alignments, (v) the curation of ligand atom and bond typing for accurate IFP analysis and (vi) weekly database updates. KLIFS is now accessible via a website (http://klifs.vu-compmedchem.nl) that provides a comprehensive visual presentation of different types of chemical, biological and structural chemogenomics data, and allows the user to easily access, compare, search and download the data.
Subfields: Computational Theory and Mathematics, Molecular Biology, Pharmacology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
In Molecular Biology
In Pharmacology
Citations in the corpus
- Mol2vec: Unsupervised Machine Learning Approach with Chemical Intuition (2018, positive): “23 The length of the target descriptor was adjusted to 2048 using a WTA-hash function to match the dimensionality of the Morgan FP. 24 Benchmarking data sets .”
- The target landscape of clinical kinase drugs (2017, background): “S4C) (5, 23, 24) confirmed that type 2 inhibitors (that is, KI binding to the inactive kinase conformation) are not necessarily more selective than type 1 inhibitors (that is, KI binding to the active kinase conformation;median CATDS of 0.”